Literature DB >> 6966908

Serological abnormalities in juvenile chronic arthritis: a review of 46 cases.

Z Balogh, K Merétey, A Falus, S Bozsóky.   

Abstract

Data of 46 patients with juvenile chronic arthritis were evaluated. All of them were under the age of 16 at the time of study. Patients with juvenile ankylosing spondylitis, psoriatic arthritis, and arthritis associated with inflammatory bowel disease were excluded from this series. Twenty-six patients had pauciarticular, 9 had systemic, 8 had polyarticular, and 3 patients had seropositive 'adult type' JCA. In all patient groups IgG, IgM, IgA, and C3 levels were significantly higher than in the control group. None of the controls but 13 of 46 patients had high IgE levels. IgA and IgG values were significantly higher in the seropositive subgroup than in the pauciarticular subgroup. There was no other positive correlation between levels of immunoglobulins, C3, and clinical features of disease. Platelet counts were significantly higher in patients with active disease. In the control group 4 out of 10 children had 'hidden' rheumatoid factor. All these children with positive findings were young.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6966908      PMCID: PMC1000495          DOI: 10.1136/ard.39.2.129

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  35 in total

1.  Prognosis in Still's disease.

Authors:  B M ANSELL; E G BYWATERS
Journal:  Bull Rheum Dis       Date:  1959-05

2.  Anti-IgG and antinuclear antibodies in juvenile rheumatoid arthritis.

Authors:  E Munthe
Journal:  Scand J Rheumatol       Date:  1972       Impact factor: 3.641

3.  [Criteria for the classification of juvenile rheumatoid arthritis].

Authors:  N Watanabe
Journal:  Ryumachi       Date:  1974-03

4.  Serum immunoglobulin and beta 1C-beta 1A globulin concentrations in juvenile rheumatoid arthritis.

Authors:  K M Goel; R W Logan; W P Barnard; R A Shanks
Journal:  Ann Rheum Dis       Date:  1974-01       Impact factor: 19.103

5.  Serum immunoglobulins in juvenile rheumatoid arthritis.

Authors:  V Houba; R Bardfeld
Journal:  Ann Rheum Dis       Date:  1969-01       Impact factor: 19.103

6.  Serum levels of immune globulins in health and disease: a survey.

Authors:  E R Stiehm; H H Fudenberg
Journal:  Pediatrics       Date:  1966-05       Impact factor: 7.124

7.  [Diagnostic criteria for juvenile rheumatoid arthritis].

Authors:  A L Laaksonen
Journal:  Duodecim       Date:  1970

8.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

9.  Antiglobulins in juvenile rheumatoid arthritis.

Authors:  J J Miller; L Olds-Arroyo; T Akasaka
Journal:  Arthritis Rheum       Date:  1977-03

10.  Platelet count and disease activity in juvenile rheumatoid arthritis.

Authors:  G K Endresen; H M Høyeraal
Journal:  Scand J Rheumatol       Date:  1977       Impact factor: 3.641

View more
  5 in total

Review 1.  Juvenile chronic arthritis, chronic iridocyclitis, and reactivity to histones.

Authors:  A M Leak; P Woo
Journal:  Ann Rheum Dis       Date:  1991-09       Impact factor: 19.103

2.  Reduction in IgG galactose in juvenile and adult onset rheumatoid arthritis measured by a lectin binding method and its relation to rheumatoid factor.

Authors:  N Sumar; D A Isenberg; K B Bodman; A Soltys; A Young; A M Leak; J Round; F C Hay; I M Roitt
Journal:  Ann Rheum Dis       Date:  1991-09       Impact factor: 19.103

3.  Immune complexes in juvenile chronic arthritis.

Authors:  U Latzka; E J Menzel; W Granninger; C Steffen
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

Review 4.  Autoantibody profile in juvenile chronic arthritis.

Authors:  A M Leak
Journal:  Ann Rheum Dis       Date:  1988-03       Impact factor: 19.103

5.  Indices of disease activity in psoriatic arthritis.

Authors:  A O Daunt; N L Cox; J C Robertson; M I Cawley
Journal:  J R Soc Med       Date:  1987-09       Impact factor: 18.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.